ARTICLE SUMMARY:
Thorasys went into business to develop a better alternative to spirometry for lung function testing, but now finds itself in possession of an oscillometry platform that’s also well-suited for identifying early stages of pneumonia in COVID-19 patients.
As of this writing, more than 300,000 people around the world have died as a result of COVID-19. No doubt it is a devastating and frightening pandemic, but it’s not without a bright side.
